LeadIQ logo
Learn more at LeadIQ.com

Insights

Funding Strength BioAge Labs recently raised $200M in an IPO, demonstrating strong investor confidence and financial backing, indicating potential for increased research and development efforts.

Industry Recognition BioAge's focus on developing novel therapies for obesity and metabolic diseases has attracted significant attention, with partnerships from Eli Lilly and renowned cardiologist Michael H. Davidson joining the board, showcasing credibility and expertise in the field.

Positive Market Response The successful filing for an IPO and attracting investments from firms like Sofinnova Partners indicate a positive market sentiment towards BioAge's innovative approach in addressing the unmet needs in obesity and metabolic diseases treatment.

Competitive Landscape With a revenue range of $10M-50M and a focus on metabolic diseases, BioAge finds itself positioned among similar companies like AiCure and Longenesis, offering potential collaboration opportunities in synergistic areas.

Employee Wellness Focus BioAge's employee-centric approach, offering comprehensive compensation packages, health benefits, and opportunities for continued learning, can be leveraged in sales pitches to showcase a supportive work environment that values employee well-being and development.

Similar companies to BioAge Labs

BioAge Labs Tech Stack

BioAge Labs uses 8 technology products and services including Google Analytics, Cloudflare CDN, Neo4j, and more. Explore BioAge Labs's tech stack below.

  • Google Analytics
    Analytics
  • Cloudflare CDN
    Content Delivery Network
  • Neo4j
    Database
  • Microsoft
    Miscellaneous
  • HTTP/3
    Miscellaneous
  • Ruby
    Programming Languages
  • Python
    Programming Languages
  • Gephi
    Visualisation Software

BioAge Labs's Email Address Formats

BioAge Labs uses at least 1 format(s):
BioAge Labs Email FormatsExamplePercentage
First@bioagelabs.comJohn@bioagelabs.com
79%
First.Last@bioagelabs.comJohn.Doe@bioagelabs.com
17%
FirstL@bioagelabs.comJohnD@bioagelabs.com
3%
Last@bioagelabs.comDoe@bioagelabs.com
1%

Frequently Asked Questions

Where is BioAge Labs's headquarters located?

Minus sign iconPlus sign icon
BioAge Labs's main headquarters is located at 1445A S 50th St Richmond, CA 94804 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is BioAge Labs's stock symbol?

Minus sign iconPlus sign icon
BioAge Labs is a publicly traded company; the company's stock symbol is BIOA.

What is BioAge Labs's official website and social media links?

Minus sign iconPlus sign icon
BioAge Labs's official website is bioagelabs.com and has social profiles on LinkedIn.

How much revenue does BioAge Labs generate?

Minus sign iconPlus sign icon
As of September 2024, BioAge Labs's annual revenue reached $15M.

What is BioAge Labs's SIC code NAICS code?

Minus sign iconPlus sign icon
BioAge Labs's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioAge Labs have currently?

Minus sign iconPlus sign icon
As of September 2024, BioAge Labs has approximately 91 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Business Officer And Head Of Brain Aging: P. L.Chief Strategy Officer: B. S.Vice President And Head Of Cmc And Supply Chain: S. K.. Explore BioAge Labs's employee directory with LeadIQ.

What industry does BioAge Labs belong to?

Minus sign iconPlus sign icon
BioAge Labs operates in the Biotechnology Research industry.

What technology does BioAge Labs use?

Minus sign iconPlus sign icon
BioAge Labs's tech stack includes Google AnalyticsCloudflare CDNNeo4jMicrosoftHTTP/3RubyPythonGephi.

What is BioAge Labs's email format?

Minus sign iconPlus sign icon
BioAge Labs's email format typically follows the pattern of . Find more BioAge Labs email formats with LeadIQ.

How much funding has BioAge Labs raised to date?

Minus sign iconPlus sign icon
As of September 2024, BioAge Labs has raised $170M in funding. The last funding round occurred on Feb 13, 2024 for $170M.

When was BioAge Labs founded?

Minus sign iconPlus sign icon
BioAge Labs was founded in 2015.
BioAge Labs

BioAge Labs

Biotechnology ResearchCalifornia, United States51-200 Employees

BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as an oral regimen to amplify weight loss and improve body composition in patients on obesity therapy with incretin drugs. BioAge’s preclinical programs address key pathways in metabolic aging, based on novel insights from its discovery platform built on human longevity data. 


BioAge offers a comprehensive compensation package, comprehensive health and wellness benefits (medical, dental, and vision insurance), childcare and fertility benefits, and a 401(k) retirement savings plan with matched employer contributions. We pride ourselves on giving employees many opportunities for career development, including a generous annual budget for continued learning and dedication to training and skill development.

At BioAge, everyone matters, and we embrace diversity and differences while we learn from each other. We are an equal opportunity employer. BioAge prohibits discrimination and harassment of any type and affords equal employment opportunities to employees and applicants without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law. BioAge conforms to the spirit as well as the letter of all applicable laws and regulations.

Section iconCompany Overview

Headquarters
1445A S 50th St Richmond, CA 94804 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BIOA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $170M

    BioAge Labs has raised a total of $170M of funding over 5 rounds. Their latest funding round was raised on Feb 13, 2024 in the amount of $170M.

  • $10M$50M

    BioAge Labs's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $170M

    BioAge Labs has raised a total of $170M of funding over 5 rounds. Their latest funding round was raised on Feb 13, 2024 in the amount of $170M.

  • $10M$50M

    BioAge Labs's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.